| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |